Nasacort aq and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort aq and Reglan. Common interactions include leukocytosis among females and dry skin among males.

The phase IV clinical study analyzes what interactions people who take Nasacort aq and Reglan have. It is created by eHealthMe based on reports of 29 people who take Nasacort aq and Reglan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 27, 2022

29 people who take Nasacort aq and Reglan together, and have interactions are studied.

What is Nasacort aq?

Nasacort aq has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 1,433 Nasacort aq users for its effectiveness, alternative drugs and more.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 28,535 Reglan users for its effectiveness, alternative drugs and more.

Number of Nasacort aq and Reglan reports submitted per year:

Common Nasacort Aq and Reglan drug interactions by gender *:

female:

Leukocytosis
Lung neoplasm
Myositis
Nasal polyps
Nasal septum deviation
Pain
Paranasal cyst
Pericardial effusion
Pleuritic pain
Abdominal pain

male:

Dry skin
Joint range of motion decreased
Skin induration
Back pain
Bone marrow depression
Depression
Hypoaesthesia
Joint swelling
Neck pain
Pain in extremity

Common Nasacort Aq and Reglan drug interactions by age *:

0-1:

n/a

2-9:

Bone marrow depression

10-19:

Electrocardiogram qt prolonged

20-29:

n/a

30-39:

Convulsion
Infusion site pain
Syncope

40-49:

Abdominal pain
Cough
Hypersensitivity
Asthma
Dyspnoea
Anaphylactic reaction
Asthenia
Atelectasis
Blood culture positive
Bone cyst

50-59:

Hyperlipidaemia
Metabolic syndrome
Obesity
Paranoia
Sinus congestion
Sleep disorder
Social avoidant behaviour
Somnolence
Tendonitis
Tooth abscess

60+:

Dry skin
Joint range of motion decreased
Skin induration
Back pain
Dizziness
Pain in extremity
Blood cholesterol increased
Cardiac failure congestive
Hypertension
Myocardial infarction

Common conditions people have *:

Asthma: 13 people, 44.83%
Depression: 8 people, 27.59%
Headache (pain in head): 8 people, 27.59%
Hypersensitivity: 8 people, 27.59%
Pain: 7 people, 24.14%
Migraine (headache): 7 people, 24.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 24.14%
Stress And Anxiety: 6 people, 20.69%
Sinusitis (inflammation of sinus): 5 people, 17.24%
Rickets (softening of bones): 5 people, 17.24%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort aq and Reglan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.